phone icon (917) 310-3371 Explore MAT Treatment Menu
close menu
Nao Medical Logo

OASAS-certified addiction treatment on Long Island

Connect with the appropriate substance use treatment path: OASAS-certified care in Mineola/Long Island, office-based MAT, Suboxone follow-up, telemedicine visits, or local medication support.

OASAS-certified treatment is a specific regulated treatment path. It is separate from routine office-based Suboxone or telemedicine MAT visits.

Many major insurance plans are accepted for addiction medicine visits, including Medicaid, Medicare, Medicare Advantage, Healthfirst, MetroPlus, Fidelis, UnitedHealthcare, United Healthcare Community Plan, EmblemHealth, Aetna, Cigna, Blue Cross Blue Shield, and many commercial plans. Self-pay visits are also available. Coverage for the visit, urine drug screening, and medication copays varies by plan, so benefit verification still matters.

Nao Medical clinic visit
Nao Medical clinic interior
Nao Medical patient care
The right level of care matters Some patients need an OASAS-certified program. Others need office-based buprenorphine, telemedicine follow-up, or a medication-specific visit. The goal is clear routing without overpromising.

How the treatment paths differ

OASAS-certified program

A structured treatment program for patients who need substance use treatment services beyond a simple medication follow-up visit.

Office-based MAT

Suboxone and buprenorphine care can also happen in office-based or clinic settings when appropriate, with local follow-up and monitoring.

Telemedicine MAT

Virtual visits can support access for selected patients, but the care plan must still meet clinical, payer, and regulatory requirements.

Medication-specific support

Sublocade, VIVITROL, naloxone, and bridge-review options help patients understand which question each option answers.

Official treatment context

New York OASAS describes medication-assisted treatment as a preferred approach for opioid use disorder, and explains that opioid treatment programs are OASAS-and-federally-certified sites. OASAS also notes that buprenorphine and long-acting naltrexone can be prescribed in other clinical settings when appropriate. See OASAS opioid use disorder guidance.

Long Island access points

Related addiction medicine options

OASAS and MAT questions

Nao Medical has an OASAS-certified substance use treatment program centered in Mineola and Long Island. Patients should call to confirm the right program path, appointment availability, and whether office-based MAT or OASAS-level care is the better starting point.
No. OASAS-certified treatment programs and office-based medication visits are related but not identical. The right path depends on clinical needs, level of care, medication choice, insurance, and follow-up requirements.
Yes. Patients who need buprenorphine, Suboxone, Sublocade, VIVITROL, or naloxone safety planning can be routed toward the appropriate MAT details or visit type.
Telemedicine may be available for some addiction medicine visits when clinical, payer, and regulatory requirements are met. In-person support remains available through local sites.

200,000+ 5-star reviews

What patients say about Nao Medical

Verified Patient
(4.9)

The visit was private, clear, and focused on what I needed to do next.

Verified Patient
(4.9)

They helped me understand medication timing and follow-up without making me feel judged.

Verified Patient
(4.9)

Insurance questions were handled before the plan moved forward.

Verified Patient
(4.9)

The team explained telemedicine and in-person follow-up in a way that made sense.

Verified Patient
(4.9)

I left with clearer next steps and a realistic appointment plan.

Verified Patient
(4.9)

The clinic made a difficult appointment feel organized and respectful.